Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TAFAMIDIS MEGLUMINE Drug Interactions: What You Need to Know

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Drug Interactions (FDA Label)

7. DRUG INTERACTIONS

7.1 BCRP Substrates Tafamidis inhibits breast cancer resistant protein (BCRP) in humans <span class="opacity-50 text-xs">[see Clinical Pharmacology (12.3) ]</span> . Coadministration of tafamidis and drugs that are BCRP substrates may increase the exposure of substrates of this transporter (e.g., methotrexate, rosuvastatin, imatinib) and the risk of the substrate-related toxicities. Monitor for signs of BCRP substrate-related toxicities and modify dosage of the substrate if appropriate.

Contraindications

4.

Contraindications

None. None. ( 4 )

More About TAFAMIDIS MEGLUMINE

TAFAMIDIS MEGLUMINE Full Profile Patient Demographics Reports by Year